COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,032 Articles (22,627 medRxiv, 8,405 bioRxiv)

Most recent first Previous |  Page 257: Articles 2561-2570  | Next

Antigen-display exosomes provide adjuvant-free protection against SARS-CoV-2 disease at nanogram levels of spike protein
Guo, C., Sachithanandham, J., Zhong, W., Craney, M., Villano, J., Pekosz, A., Gould, S.
10.1101/2024.01.04.574272 — Posted: 2024-01-05
Longitudinal transcriptional changes reveal genes from the natural killer cell-mediated cytotoxicity pathway as critical players underlying COVID-19 progression
Medina, M. A., Fuentes-Villalobos, F., Quevedo, C., Aguilera, F., Riquelme, R., Rioseco, M. L., Barria, S., Pinos, Y., Calvo, M., Burbulis, I., Alvarez, R. A., Garrido, J. L., Barria, M. I.
10.1101/2024.01.02.573936 — Posted: 2024-01-05
Automated Classification of At-home SARS-CoV-2 Lateral Flow Assay Test Results using Image Matching and Transfer Learning: multiple-pipeline study
Safarzadeh, M., Herbert, C., Wong, S. K., Stamegna, P., Guilarte-Walker, Y., Wright, C., Suvarna, T., Nowak, C., Kheterpal, V., Pandey, S., Wang, B., Lin, H., O'Connor, L., Hafer, N., Luzuriaga, K., Manabe, Y., Broach, J., Zai, A. H., McManus, D. D., Du, X., Soni, A.
10.1101/2024.01.04.24300836 — Posted: 2024-01-04
Mutation of highly conserved residues in loop 2 of the coronavirus macrodomain demonstrates that enhanced ADP-ribose binding is detrimental to infection
Kerr, C. M., Pfannenstiel, J. J., Alhammad, Y. M., Roy, A., O'Connor, J. J., Ghimire, R., Khattabi, R., Shrestha, R., McDonald, P. R., Gao, P., Johnson, D. K., More, S., Channappanavar, R., Fehr, A. R.
10.1101/2024.01.03.574082 — Posted: 2024-01-04
Antiviral action of different molecules obtained from invertebrates against coronavirus
Mendonca, R. Z., Nascimento, R. M., Fernandes, A. C. O., de Almeida, M. I. P., Junior, P. I. S.
10.1101/2024.01.04.574161 — Posted: 2024-01-04
Stably-Inverted Apical-Out Human Upper Airway Organoids for SARS-CoV-2 Infection and Therapeutic Testing
Lee, J.-H., LeCher, J. C., Parigoris, E., Shinagawa, N., Sentosa, J., Manfredi, C., Goh, S. L., De, R., Tao, S., Zandi, K., Amblard, F., Sorscher, E. J., Spence, J. R., Tirouvanziam, R., Schinazi, R. F., Takayama, S.
10.1101/2024.01.02.573939 — Posted: 2024-01-04
Lethal Infection of Human ACE2-Transgenic Mice Caused by SARS-CoV-2-related Pangolin Coronavirus GX_P2V(short_3UTR)
Wei, L., Liu, S., Lu, S., Luo, S., An, X., Fan, H., Chen, W., Li, E., Tong, Y., Song, L.
10.1101/2024.01.03.574008 — Posted: 2024-01-04
A Murine Model of Post-acute Neurological Sequelae Following SARS-CoV-2 Variant Infection
Singh, A., Adam, A., Aditi, A., Peng, B.-H., Yu, X., Zou, J., Kulkarni, V. V., Kan, P., Jiang, W., Shi, P.-Y., Samir, P., Cisneros, I., Wang, T.
10.1101/2024.01.03.574064 — Posted: 2024-01-04
Prototype mRNA vaccines imprint broadly neutralizing human serum antibodies after Omicron variant-matched boosting
Liang, C.-Y., Raju, S., Liu, Z., Li, Y., Arunkumar, G. A., Case, J. B., Zost, S. J., Acreman, C. M., Carvalho dos Anjos, D. C., McLellan, J. S., Crowe, J. E., Whelan, S. P. J., Elbashir, S. M., Edwards, D. K., Diamond, M. S.
10.1101/2024.01.03.574018 — Posted: 2024-01-04
Quantifying the impact of social activities on SARS-CoV-2 transmission using Google mobility reports
Günther, F., Brustad, H. K., Frigessi, A., Britton, T.
10.1101/2024.01.03.24300755 — Posted: 2024-01-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).